SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-17-027650
Filing Date
2017-05-15
Accepted
2017-05-15 17:25:22
Documents
57
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v466994_10q.htm 10-Q 423872
2 EXHIBIT 31.1 v466994_ex31-1.htm EX-31.1 9193
3 EXHIBIT 32.1 v466994_ex32-1.htm EX-32.1 4080
  Complete submission text file 0001144204-17-027650.txt   4219180

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT nwbo-20170331.xml EX-101.INS 911276
5 XBRL TAXONOMY EXTENSION SCHEMA nwbo-20170331.xsd EX-101.SCH 44209
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nwbo-20170331_cal.xml EX-101.CAL 35438
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nwbo-20170331_def.xml EX-101.DEF 354312
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE nwbo-20170331_lab.xml EX-101.LAB 318847
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nwbo-20170331_pre.xml EX-101.PRE 361659
Mailing Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814
Business Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814 (240) 497-9024
NORTHWEST BIOTHERAPEUTICS INC (Filer) CIK: 0001072379 (see all company filings)

IRS No.: 943306718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35737 | Film No.: 17846001
SIC: 2834 Pharmaceutical Preparations